The LLS Patient Aid Program provides financial assistance to blood cancer patients. Eligible patients will receive a one-time $100 stipend to help offset non-medical expenses like transportation, food, housing, utilities, etc. There are no income criteria to qualify for this program; patients can be insured or uninsured.
Full Answer
What is Lorbrena ® (lorlatinib)?
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of your body. Your healthcare provider will perform a test to make sure that LORBRENA is right for you.
What do I need to know about Lorbrena before starting treatment?
Hear from real LORBRENA patients about their experiences navigating diagnosis and their treatment journey. If your doctor prescribed LORBRENA, it’s important to understand the treatment and also the potential side effects that you may experience. As you begin treatment with LORBRENA, it may be helpful to learn more about what to expect.
How much does Lorbrena cost at the pharmacy?
Lorbrena Prices. This Lorbrena price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Lorbrena oral tablet 25 mg is around $5,597 for a supply of 30 tablets, depending on the pharmacy you visit.
What is the Pfizer Patient Assistance Program?
Pfizer Patient Assistance Program Provides free Pfizer medicines to eligible patients through their doctor's office or at home. To qualify, patients must: Have a valid prescription for the Pfizer medicine for which they are seeking assistance.
Is Lorlatinib chemo?
Lorlatinib (LOR) or pemetrexed-based chemotherapy (PEM) is the standard treatment after failure of a second-generation ALK tyrosine kinase inhibitor, such as alectinib, in patients with ALK-positive NSCLC. Nevertheless, there have been few data on the clinical outcomes of these treatments after alectinib failure.
How do you take Lorlatinib?
Lorlatinib comes as a tablet to take by mouth. It is usually taken with or without food once daily. Take lorlatinib at around the same time every day.
What is Pfizer Oncology together?
Pfizer Oncology Together is a personalized patient support program that offers resources for patients prescribed Pfizer Oncology medicines. We provide access and reimbursement support, as well as help identifying financial assistance options, so patients can get their prescribed Pfizer Oncology medicines.
How effective is Lorlatinib?
For lorlatinib, the objective response rate was 35.7%, and disease control rate was 64.3%. Their progression-free survival (PFS) was 6.2 months.
Is Lorbrena targeted therapy?
Drug Type: Lorlatinib is a targeted therapy (for more detail, see "How Lorlatinib Works" section below).
Is lorlatinib better than Alectinib?
Data from the phase 3 CROWN trial (NCT03052608) showed that lorlatinib was superior in terms of efficacy vs crizotinib. Although lorlatinib could have better CNS activity vs alectinib, lorlatinib is associated with neurologic toxicities, such as neurocognitive complications, ataxia, and dizziness.
Is lorlatinib FDA approved?
On March 3, 2021, the Food and Drug Administration granted regular approval to lorlatinib (Lorbrena, Pfizer Inc.) for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, detected by an FDA-approved test.
What company makes lorlatinib?
U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC. NEW YORK--(BUSINESS WIRE )--Pfizer Inc.
What is the copay for Ibrance?
With this card, eligible patients will pay a $0 co-pay per eligible monthly prescription, subject to a maximum amount of $25,000 per calendar year. The amount of any benefit is the difference between your co-pay and $0.
What is Pfizer enCompass?
Pfizer enCompass offers various services to patients including reimbursement support for insured patients; co-pay assistance for eligible commercially insured patients who cannot afford their co-pays, co-insurances, or deductibles; and a free medicine patient assistance program for eligible uninsured or underinsured ...
What is on oncology?
A branch of medicine that specializes in the diagnosis and treatment of cancer.
What type of drug is lorlatinib?
Lorlatinib is an antineoplastic (cancer) agent. It interferes with the growth of cancer cells, which are eventually destroyed by the body. This medicine is available only with your doctor's prescription.
Is lorlatinib better than Alectinib?
Data from the phase 3 CROWN trial (NCT03052608) showed that lorlatinib was superior in terms of efficacy vs crizotinib. Although lorlatinib could have better CNS activity vs alectinib, lorlatinib is associated with neurologic toxicities, such as neurocognitive complications, ataxia, and dizziness.
Is lorlatinib FDA approved?
On March 3, 2021, the Food and Drug Administration granted regular approval to lorlatinib (Lorbrena, Pfizer Inc.) for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, detected by an FDA-approved test.
Who developed lorlatinib?
Lorlatinib, sold under the brand name Lorbrena in the United States, Canada, and Japan, and Lorviqua in the European Union, is an anti-cancer drug developed by Pfizer. It is an orally administered inhibitor of ALK and ROS1, two enzymes that play a role in the development of cancer.
What is lungevity foundation?
LUNGevity Foundation is committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer, as well as providing community, support, and education for all those affected by the disease.
What is Pfizer Oncology Together?
By checking this box, I also agree to receive communications from Pfizer Oncology Together, a support program that offers financial assistance and personalized resources for patients prescribed Pfizer Oncology medicines.
Can you use a medicaid card in Puerto Rico?
Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
Is Pfizer Savings Program a health insurance program?
with distinct legal restrictions. § The Pfizer Savings Program is not health insurance. For more information, call the toll-free number: 1-877-744-5675 . There are no membership fees to participate in this program.
What is Lorbrena used for?
LORBRENA ® is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of your body.
What to tell your doctor before taking Lorbrena?
Before taking LORBRENA, tell your healthcare provider about all of your medical conditions, including if you: have kidney problems. have had episodes of depression or seizures. have high levels of cholesterol or triglycerides in your blood. have problems with your heartbeat. have lung or breathing problems.
How long after Lorbrena can you breastfeed?
are breastfeeding or plan to breastfeed. It is not known if LORBRENA passes into your breast milk. Do not breastfeed during treatment with LORBRENA and for 7 days after the final dose. Talk to your healthcare provider about the best way to feed your baby during this time.
How long after Lorbrena can you use birth control?
–Males who have female partners who are able to become pregnant should use effective birth control during treatment with LORBRENA and for at least 3 months after the final dose of LORBRENA.
How long does it take for a lipid to be checked before taking Lorbrena?
Your healthcare provider should do blood tests to check the lipid levels in your blood before starting treatment, 1 to 2 months after starting treatment, and during treatment with LORBRENA. Heart problems. LORBRENA may cause very slow or abnormal heartbeats.
Does Lorbrena affect fertility?
LORBRENA may cause decreased fertility in males. In males, this could affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.
Does Lorbrena affect the nervous system?
LORBRENA may cause CNS effects, including problems with thinking (such as forgetfulness or confusion), changes in mood (such as depression and thoughts about suicide or dying), psychotic effects such as seeing or hearing things that are not real (hallucinations), seizures, changes in speech and changes in sleep. Tell your healthcare provider if you experience new or worsening symptoms of CNS effects.
What is lungevity foundation?
LUNGevity Foundation is committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer, as well as providing community, support, and education for all those affected by the disease.
What is Pfizer Oncology Together?
By checking this box, I also agree to receive communications from Pfizer Oncology Together, a support program that offers financial assistance and personalized resources for patients prescribed Pfizer Oncology medicines.
Can you use a medicaid card in Puerto Rico?
Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
Is Pfizer Savings Program a health insurance program?
with distinct legal restrictions. § The Pfizer Savings Program is not health insurance. For more information, call the toll-free number: 1-877-744-5675 . There are no membership fees to participate in this program.
What is lungevity foundation?
LUNGevity Foundation is committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer, as well as providing community, support, and education for all those affected by the disease.
What is Pfizer Oncology Together?
By checking this box, I also agree to receive communications from Pfizer Oncology Together, a support program that offers financial assistance and personalized resources for patients prescribed Pfizer Oncology medicines.
Is the offer valid for cash paying patients?
Patient must have private insurance. Offer is not valid for cash-paying patients.
Can you use a medicaid card in Puerto Rico?
Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
When does Lorbrena Pfizer Oncology rebate expire?
Expires. December 31, 2022. Form more information phone: 877-744-5675 or Visit website. Lorbrena Pfizer Oncology Together Mail-In Rebate: If a pharmacy does not accept the Savings Card the patient may submit a request for a rebate in connection with the offer; for additional information contact the program at 877-744-5675.
How much does Lorbrena Pfizer pay per year?
Lorbrena Pfizer Oncology Together Co-Pay Savings Program: Eligible commercially insured patients may pay $0 per prescription with a maximum savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
What is Lorbrena used for?
Lorbrena (lorlatinib) is a member of the multikinase inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer.
Is Lorbrena a generic?
Lorbrena is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Lorbrena availability . This Lorbrena price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
What is the lung cancer foundation?
Lung Cancer Foundation of America aims to improve the survivorship of lung cancer patients through the funding of transformative science. LungCancer.org. www.lungcancer.org. Lungcancer.org was founded by CancerCare to be a source of support and information for lung cancer patients and their loved ones.
What is Pfizer Oncology Together?
By checking this box, I also agree to receive communications from Pfizer Oncology Together, a support program that offers financial assistance and personalized resources for patients prescribed Pfizer Oncology medicines.
Can you use a medicaid card in Puerto Rico?
Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
What is Lorlatinib used for?from pfizer.com
Lorlatinib was specifically designed to inhibit tumor mutations that drive resistance to other ALK inhibitors and to penetrate the blood brain barrier. Lorlatinib is an investigational agent and has not received regulatory approval for any indication anywhere in the world. About Pfizer Oncology.
What is the next generation of lorlatinib?from pfizer.com
Pfizer Inc. today announced that its investigational next-generation ALK/ROS1 tyrosine kinase inhibitor, lorlatinib, was granted Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), previously treated with one or more ALK inhibitors.
What is Pfizer's mission?from pfizer.com
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @PfizerNews, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
How long after taking Lorbrena can you take bilirubin?from pfizer.com
If concomitant use of moderate CYP3A inducers cannot be avoided, monitor AST, ALT, and bilirubin 48 hours after initiating LORBRENA and at least 3 times during the first week after initiating LORBRENA.
Does Pfizer have oncology?from pfizer.com
Because Pfizer Oncology knows that success in oncology is not measured solely by the medicines you manufacture, but rather by the meaningful partnerships you make to have a more positive impact on people’s lives. Pfizer Inc.: Working together for a healthier world®.
Is Xalkori approved for ROS1?from pfizer.com
XALKORI has received approval for patients with ALK-positive NSCLC in more than 90 countries including Australia, Canada, China, Japan, South Korea and the European Union. XALKORI is also approved for ROS1-positive NSCLC in more than 60 countries. The full prescribing information for XALKORI can be found here .
Is Lorbrena safe for renal impairment?from pfizer.com
Renal Impairment: No dose adjustment is recommended for patients with mild or moderate renal impairment. The recommended dose of LORBRENA has not been established for patients with severe renal impairment.
